Register Login

Moderna Inc (MRNA)

(75% Positive) Moderna Inc (MRNA) Announces Enrollment Update for disease Due to Pandemic-Related Challenges, Patient Enrollment Issues

Full text
Register to leave comments
  • News bot Jan. 29, 2026, 8:53 p.m.

    📋 Moderna Inc (MRNA) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 07:01:10

    Event Type: Clinical Trial Update

    Event Details:

    Moderna Inc (MRNA) Announces Clinical Trial Update Moderna Inc (MRNA) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: disease, readouts
    • Diseases/Conditions: oncology
    • Clinical Stage: pivotal trial
    • Collaboration: Moderna, Inc.
      • expected in 2026

    🔬 Clinical Development Pipeline (Moderna Inc):

    Product Type Development Stage Therapeutic Area Source
    Intismeran autogene BIOLOGICAL Phase PHASE3 Carcinoma, Non-Small-Cell Lung ClinicalTrials.gov
    mRNA-4359 BIOLOGICAL Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Influenza Vaccine 2 BIOLOGICAL Phase PHASE1 SARS-CoV-2 ClinicalTrials.gov
    mRNA-1010 BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    mRNA-1083 BIOLOGICAL Phase PHASE1 SARS-CoV-2 ClinicalTrials.gov
    mRNA-3705 BIOLOGICAL Phase PHASE1 Methylmalonic Acidemia ClinicalTrials.gov
    mRNA-1403 BIOLOGICAL Phase PHASE3 Acute Gastroenteritis ClinicalTrials.gov
    Placebo OTHER Phase PHASE3 Carcinoma, Non-Small-Cell Lung ClinicalTrials.gov
    Paclitaxel DRUG Phase PHASE3 Carcinoma, Non-Small-Cell Lung ClinicalTrials.gov
    Gemcitabine DRUG Phase PHASE3 Carcinoma, Non-Small-Cell Lung ClinicalTrials.gov
    Pemetrexed DRUG Phase PHASE3 Carcinoma, Non-Small-Cell Lung ClinicalTrials.gov
    Carboplatin DRUG Phase PHASE3 Carcinoma, Non-Small-Cell Lung ClinicalTrials.gov
    Cisplatin DRUG Phase PHASE3 Carcinoma, Non-Small-Cell Lung ClinicalTrials.gov
    Pembrolizumab BIOLOGICAL Phase PHASE3 Carcinoma, Non-Small-Cell Lung ClinicalTrials.gov
    BCG BIOLOGICAL Phase PHASE2 Urinary Bladder Neoplasms ClinicalTrials.gov
    mRNA-3927 BIOLOGICAL Phase PHASE1 Propionic Acidemia ClinicalTrials.gov
    mRNA-0184 DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov
    mRNA-1283 BIOLOGICAL Phase PHASE4 SARS-CoV-2 ClinicalTrials.gov
    mRNA-1273 BIOLOGICAL Phase PHASE4 SARS-CoV-2 ClinicalTrials.gov
    mRNA-1645-N332GT5 BIOLOGICAL Phase PHASE1 HIV Infections ClinicalTrials.gov
    mRNA-1645-CoreG28v2 BIOLOGICAL Phase PHASE1 HIV Infections ClinicalTrials.gov
    mRNA-1645-eODGT8 BIOLOGICAL Phase PHASE1 HIV Infections ClinicalTrials.gov
    Surgery (RC plus PLND) PROCEDURE Phase PHASE1 Bladder Cancer ClinicalTrials.gov
    Enfortumab Vedotin BIOLOGICAL Phase PHASE1 Bladder Cancer ClinicalTrials.gov
    Nab-paclitaxel DRUG Phase PHASE2 Squamous Non-small Cell Lung Cancer ClinicalTrials.gov
    V940 BIOLOGICAL Phase PHASE2 Squamous Non-small Cell Lung Cancer ClinicalTrials.gov
    mRNA-4203 BIOLOGICAL Phase PHASE1 Cutaneous Melanoma ClinicalTrials.gov
    IMA203 BIOLOGICAL Phase PHASE1 Cutaneous Melanoma ClinicalTrials.gov
    mRNA-1273.214 BIOLOGICAL Phase PHASE3 Respiratory Syncytial Virus ClinicalTrials.gov
    Afluria® Quadrivalent BIOLOGICAL Phase PHASE3 Respiratory Syncytial Virus ClinicalTrials.gov
    mRNA-1345 BIOLOGICAL Phase PHASE3 Respiratory Syncytial Virus ClinicalTrials.gov
    COVID-19 Vaccine 2 BIOLOGICAL Phase PHASE1 SARS-CoV-2 ClinicalTrials.gov
    Investigational COVID-19 Vaccine 2 BIOLOGICAL Phase PHASE1 SARS-CoV-2 ClinicalTrials.gov
    Investigational Influenza Vaccine 2 BIOLOGICAL Phase PHASE1 SARS-CoV-2 ClinicalTrials.gov
    COVID-19 Vaccine 1 BIOLOGICAL Phase PHASE1 SARS-CoV-2 ClinicalTrials.gov
    Investigational COVID-19 Vaccine 1 BIOLOGICAL Phase PHASE1 SARS-CoV-2 ClinicalTrials.gov
    Investigational Influenza Vaccine 1 BIOLOGICAL Phase PHASE1 SARS-CoV-2 ClinicalTrials.gov
    mRNA-1083.3 BIOLOGICAL Phase PHASE1 SARS-CoV-2 ClinicalTrials.gov
    mRNA-1083.2 BIOLOGICAL Phase PHASE1 SARS-CoV-2 ClinicalTrials.gov
    mRNA-1083.1 BIOLOGICAL Phase PHASE1 SARS-CoV-2 ClinicalTrials.gov
    Influenza Vaccine 1 BIOLOGICAL Phase PHASE1 SARS-CoV-2 ClinicalTrials.gov
    mRNA-1195 BIOLOGICAL Phase PHASE2 Multiple Sclerosis ClinicalTrials.gov
    mRNA-1647 BIOLOGICAL Phase PHASE3 Cytomegalovirus Infection ClinicalTrials.gov
    mRNA-3745 DRUG Phase PHASE1 Glycogen Storage Disease ClinicalTrials.gov
    mRNA-1273 (Moderna COVID-19 vaccine) BIOLOGICAL Phase PHASE4 COVID-19 ClinicalTrials.gov
    Surgery PROCEDURE Phase PHASE2 Carcinoma, Squamous Cell ClinicalTrials.gov
    mRNA-4157 DRUG Phase PHASE2 Melanoma ClinicalTrials.gov
    SARS-CoV-2 Vaccine BIOLOGICAL Phase PHASE3 COVID-19 ClinicalTrials.gov
    Licensed Influenza Vaccine BIOLOGICAL Phase PHASE3 COVID-19 ClinicalTrials.gov
    SoC Treatment BIOLOGICAL Phase PHASE1 Solid Tumors ClinicalTrials.gov
    mRNA-1273.815 BIOLOGICAL Phase PHASE3 SARS-CoV-2 ClinicalTrials.gov
    mRNA-1045 BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    Inactivated Influenza Vaccine BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    Adjuvanted Quadrivalent Influenza Vaccine BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    Egg-based Quadrivalent Influenza Vaccine BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    Nimenrix DRUG Phase PHASE1 Respiratory Syncytial Virus ClinicalTrials.gov
    mRNA-1365 BIOLOGICAL Phase PHASE1 Respiratory Syncytial Virus ClinicalTrials.gov
    mRNA-1273 Variant-containing Formulation BIOLOGICAL Phase PHASE4 SARS-CoV-2 ClinicalTrials.gov
    mRNA -1215 BIOLOGICAL Phase PHASE1 Nipah Virus Infection ClinicalTrials.gov
    Investigational COVID-19 Vaccine Lot B BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    Investigational COVID-19 Vaccine Lot A BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    Investigational Influenza Vaccine BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    COVID-19 Vaccine BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    Influenza Vaccine BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    mRNA-1083 Composition 3 Dose B BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    mRNA-1083 Composition 3 Dose A BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    mRNA-1083 Composition 2 Dose B BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    mRNA-1083 Composition 2 Dose A BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    mRNA-1083 Composition 1 Dose C BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    mRNA-1083 Composition 1 Dose B BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    mRNA-1083 Composition 1 Dose A Lot B BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    mRNA-1083 Composition 1 Dose A Lot A BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    mRNA-2808 DRUG Phase PHASE1 Relapsed or Refractory Multiple Myeloma ClinicalTrials.gov
    mRNA-1283.251 Variant-containing Formulation BIOLOGICAL Phase PHASE4 COVID-19 ClinicalTrials.gov
    Nivolumab BIOLOGICAL Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Ipilimumab BIOLOGICAL Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    mRNA-1189 BIOLOGICAL Phase PHASE1 Epstein-Barr Virus Infection ClinicalTrials.gov
    mRNA-1195.2 BIOLOGICAL Phase PHASE1 Epstein-Barr Virus Infection ClinicalTrials.gov
    mRNA-1195.1 BIOLOGICAL Phase PHASE1 Epstein-Barr Virus Infection ClinicalTrials.gov
    mRNA-1893 BIOLOGICAL Phase PHASE2 Zika Virus ClinicalTrials.gov
    mRNA-1273.222 BIOLOGICAL Phase PHASE2 SARS-CoV-2 ClinicalTrials.gov
    mRNA-1653 BIOLOGICAL Phase PHASE1 Human Metapneumovirus and Human Parainfluenza Infection ClinicalTrials.gov
    mRNA-1443 BIOLOGICAL Phase PHASE1 Cytomegalovirus Infection ClinicalTrials.gov
    mRNA-3704 BIOLOGICAL Phase PHASE1 Methylmalonic Acidemia (MMA) ClinicalTrials.gov
    mRNA-1944 BIOLOGICAL Phase PHASE1 Prevention of Chikungunya Virus Infection ClinicalTrials.gov
    VAL-339851 BIOLOGICAL Phase PHASE1 Influenza ClinicalTrials.gov
    VAL-506440 BIOLOGICAL Phase PHASE1 Influenza ClinicalTrials.gov
    mRNA-6231 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    mRNA-1273.351 BIOLOGICAL Phase PHASE2 SARS-CoV-2 ClinicalTrials.gov
    Biological: mRNA-1273 BIOLOGICAL Phase PHASE2 SARS-CoV-2 ClinicalTrials.gov
    mRNA-2736 BIOLOGICAL Phase PHASE1 Relapsed or Refractory Multiple Myeloma ClinicalTrials.gov
    Wireless wearable digital devices DEVICE Preclinical Healthy Participants ClinicalTrials.gov
    eOD-GT8 60mer mRNA Vaccine (100µg) BIOLOGICAL Phase PHASE1 HIV-1-infection ClinicalTrials.gov
    VAL-181388 BIOLOGICAL Phase PHASE1 Chikungunya Virus ClinicalTrials.gov
    mRNA-1325 BIOLOGICAL Phase PHASE1 Zika Virus ClinicalTrials.gov
    mRNA-1073 BIOLOGICAL Phase PHASE1 SARS-CoV-2 ClinicalTrials.gov
    Patient Reported Outcomes OTHER Preclinical Multiple Myeloma ClinicalTrials.gov
    Active Comparator BIOLOGICAL Phase PHASE1 Seasonal Influenza ClinicalTrials.gov
    mRNA-1020 BIOLOGICAL Phase PHASE1 Seasonal Influenza ClinicalTrials.gov
    mRNA-1030 BIOLOGICAL Phase PHASE1 Seasonal Influenza ClinicalTrials.gov
    mRNA-1273.529 BIOLOGICAL Phase PHASE2 SARS-CoV-2 ClinicalTrials.gov
    Durvalumab BIOLOGICAL Phase PHASE1 Relapsed/Refractory Solid Tumor Malignancies or Lymphoma ClinicalTrials.gov
    mRNA-2416 BIOLOGICAL Phase PHASE1 Relapsed/Refractory Solid Tumor Malignancies or Lymphoma ClinicalTrials.gov
    mRNA-1230 BIOLOGICAL Phase PHASE1 SARS-CoV-2 ClinicalTrials.gov
    Pfizer-BioNTech COVID-19 Vaccine BNT162b2 (30 µg)( Comirnaty®) BIOLOGICAL Phase PHASE3 Immunocompromised Patients ClinicalTrials.gov
    Moderna COVID-19 Vaccine, mRNA-1273 (100 μg) BIOLOGICAL Phase PHASE3 Immunocompromised Patients ClinicalTrials.gov
    Pfizer 2023 Updated COVID-19 vaccine (XBB.1.5) BIOLOGICAL Preclinical COVID-19 ClinicalTrials.gov
    Moderna 2023 Updated COVID-19 vaccine (XBB.1.5) BIOLOGICAL Preclinical COVID-19 ClinicalTrials.gov
    Pfizer COVID-19 Vaccine BIOLOGICAL Preclinical COVID-19 ClinicalTrials.gov
    Moderna mRNA1273.222 Booster BIOLOGICAL Preclinical COVID-19 ClinicalTrials.gov
    Moderna COVID-19 Vaccine BIOLOGICAL Preclinical COVID-19 ClinicalTrials.gov
    eOD-GT8 60mer mRNA Vaccine BIOLOGICAL Phase PHASE1 Hiv ClinicalTrials.gov
    Core-g28v2 60mer mRNA Vaccine BIOLOGICAL Phase PHASE1 Hiv ClinicalTrials.gov
    MRNA-1273.222 Vaccine BIOLOGICAL Phase PHASE2 COVID-19 Pandemic ClinicalTrials.gov
    MRNA-1273 Vaccine BIOLOGICAL Phase PHASE2 COVID-19 Pandemic ClinicalTrials.gov
    mRNA-1273.214 Vaccine BIOLOGICAL Phase PHASE2 COVID-19 Pandemic ClinicalTrials.gov
    V941 BIOLOGICAL Phase PHASE1 Neoplasms ClinicalTrials.gov
    mRNA-1982 BIOLOGICAL Phase PHASE1 Lyme Disease ClinicalTrials.gov
    mRNA-1975 BIOLOGICAL Phase PHASE1 Lyme Disease ClinicalTrials.gov
    BEXSERO BIOLOGICAL Phase PHASE1 Genital Herpes ClinicalTrials.gov
    mRNA-1608 BIOLOGICAL Phase PHASE1 Genital Herpes ClinicalTrials.gov
    mRNA-1769 BIOLOGICAL Phase PHASE1 Smallpox ClinicalTrials.gov
    SPIKEVAX BIOLOGICAL Preclinical SARS-CoV-2 ClinicalTrials.gov
    mRNA-1283.529 BIOLOGICAL Phase PHASE2 SARS-CoV-2 ClinicalTrials.gov
    mRNA-1283.211 BIOLOGICAL Phase PHASE2 SARS-CoV-2 ClinicalTrials.gov
    mRNA-1283.815 BIOLOGICAL Phase PHASE3 COVID-19 ClinicalTrials.gov
    mRNA-1283.222 BIOLOGICAL Phase PHASE3 COVID-19 ClinicalTrials.gov
    mRNA-1405 BIOLOGICAL Phase PHASE1 Norovirus Acute Gastroenteritis ClinicalTrials.gov
    Licensed Spikevax Vaccine BIOLOGICAL Phase PHASE3 SARS-CoV-2 ClinicalTrials.gov
    Investigational mRNA-1273.815 BIOLOGICAL Phase PHASE3 SARS-CoV-2 ClinicalTrials.gov
    mRNA-1283 Variant-containing Formulation BIOLOGICAL Phase PHASE4 COVID-19 ClinicalTrials.gov
    Nivolumab/Relatlimab BIOLOGICAL Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    mRNA-4106 BIOLOGICAL Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Alpharix® Tetra BIOLOGICAL Phase PHASE3 Seasonal Influenza ClinicalTrials.gov
    Fluarix Tetra BIOLOGICAL Phase PHASE3 Seasonal Influenza ClinicalTrials.gov
    Influsplit® Tetra BIOLOGICAL Phase PHASE3 Seasonal Influenza ClinicalTrials.gov
    Fluarix® BIOLOGICAL Phase PHASE3 Seasonal Influenza ClinicalTrials.gov
    Patient letter and clinician communication BEHAVIORAL Approved COVID-19 Immunisation ClinicalTrials.gov
    FLUAD® BIOLOGICAL Phase PHASE1 SARS-CoV-2 ClinicalTrials.gov
    Shingrix BIOLOGICAL Phase PHASE1 Herpes Zoster ClinicalTrials.gov
    mRNA-1468 BIOLOGICAL Phase PHASE1 Herpes Zoster ClinicalTrials.gov
    mRNA-1273.712 BIOLOGICAL Phase PHASE4 Healthy Volunteers ClinicalTrials.gov
    mRNA-1010.3 BIOLOGICAL Phase PHASE1 Seasonal Influenza ClinicalTrials.gov
    mRNA-1010.2 BIOLOGICAL Phase PHASE1 Seasonal Influenza ClinicalTrials.gov
    mRNA-1012.1 BIOLOGICAL Phase PHASE1 Seasonal Influenza ClinicalTrials.gov
    mRNA-1011.2 BIOLOGICAL Phase PHASE1 Seasonal Influenza ClinicalTrials.gov
    mRNA-1011.1 BIOLOGICAL Phase PHASE1 Seasonal Influenza ClinicalTrials.gov
    SPIKEVAX X BIOLOGICAL Preclinical SARS-CoV-2 ClinicalTrials.gov
    SPIKEVAX Bivalent BIOLOGICAL Preclinical SARS-CoV-2 ClinicalTrials.gov
    mRNA-1018 for H5 Only-CG BIOLOGICAL Phase PHASE1 Influenza ClinicalTrials.gov
    mRNA-1018 for H7 Only BIOLOGICAL Phase PHASE1 Influenza ClinicalTrials.gov
    mRNA-1018 for H5 Only BIOLOGICAL Phase PHASE1 Influenza ClinicalTrials.gov
    mRNA-1018 for H7N9 BIOLOGICAL Phase PHASE1 Influenza ClinicalTrials.gov
    mRNA-1018 for H5N8 BIOLOGICAL Phase PHASE1 Influenza ClinicalTrials.gov
    Fluarix Quadrivalent BIOLOGICAL Phase PHASE3 Seasonal Influenza ClinicalTrials.gov
    Intralesional mRNA 2752 BIOLOGICAL Phase EARLY_PHASE1 Carcinoma, Intraductal, Noninfiltrating ClinicalTrials.gov
    Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine BIOLOGICAL Phase PHASE3 Seasonal Influenza ClinicalTrials.gov
    Fluzone HD BIOLOGICAL Phase PHASE3 Respiratory Syncytial Virus ClinicalTrials.gov
    mRNA-1010.6 BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    mRNA-1010.4 BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    mRNA-1273.231 BIOLOGICAL Phase PHASE2 SARS-CoV-2 ClinicalTrials.gov
    mRNA-1273.213 BIOLOGICAL Phase PHASE2 SARS-CoV-2 ClinicalTrials.gov
    mRNA-1273.617.2 BIOLOGICAL Phase PHASE2 SARS-CoV-2 ClinicalTrials.gov
    mRNA-1273.211 BIOLOGICAL Phase PHASE2 SARS-CoV-2 ClinicalTrials.gov
    mRNA-3210 DRUG Phase PHASE1 Phenylketonuria ClinicalTrials.gov
    No intervention OTHER Preclinical SARS-CoV-2 Infection ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Moderna Inc
    • Ticker Symbol: MRNA

Search

News categories